AAAAAA

   
Results: 1-3 |
Results: 3
Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features
Authors: Geradts, J Fong, KM Zimmerman, PV Minna, JD
Citation: J. Geradts et al., Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features, BR J CANC, 82(6), 2000, pp. 1191-1197
Correlation of abnormal RB, p16(ink4a), and p53 expression with 3p loss ofheterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers
Authors: Geradts, J Fong, KM Zimmerman, PV Maynard, R Minna, JD
Citation: J. Geradts et al., Correlation of abnormal RB, p16(ink4a), and p53 expression with 3p loss ofheterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers, CLIN CANC R, 5(4), 1999, pp. 791-800
Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity
Authors: Devine, PL Siebert, WJ Morton, SL Scells, B Quin, RJ Heddle, WF Zimmerman, PV Donohoe, PJ
Citation: Pl. Devine et al., Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity, DIS MARKER, 14(3), 1998, pp. 169-175
Risultati: 1-3 |